Искусственные генетические системы. Том 1 - Патрушев Л.И.
Скачать (прямая ссылка):
173. Lindbladh C., Persson М., Bulow L., Mosbach K. Characterization of recombinant galactose dehydrogenase/luciferase, displaying an improved
bioluminescence in a three-enzyme system // Europ. J. Biochem. 1991. Vol. 204. P. 241-247.
174. Lindbladh C., Rault М., Hagglund C. et al. Preparation and kinetic characterization of a fusion protein of yeast mitochondrial citrate synthase and malate dehydrogenase // Biochemistry. 1994. Vol. 33. P. 11692-11698.
175. Beguin P., Lemaire M. The cellulosome: An exocellular, multiprotein complex specialized in cellulose degradation // Crit. Rev. Biochem. Mol. Biol. 1996. Vol. 31. P. 201-236.
176. Bayer E.A., Morag E., Lamed R. The cellulosome - a treasure-trove for biotechnology //Trends Biotechnol. 1994. Vol. 12. P. 379-386.
177. Leibovitz E., Beguin P. Comparison of two scaffolding polypeptides for the integration of different proteins in synthetic complexes derived from the Clostridium thermocellum cellulosome // Enzyme Microb. Technol.
1998. Vol. 22. P. 588-593.
178. Pages S., Belal'ch A., Bela'ich J.-P. et al. Species specificity of the cohesin-dockerin interaction between Clostridium thermocellum and Clostridium cellulolyticum - prediction of specificity determinants of the dockerin domain // Proteins. 1997. Vol. 29. P. 517-527.
179. Hopfner K.-P., Kopetzki E., Krefie G.-B. et al. New enzyme lineages by subdomain shuffling // Proc. Nat. Acad. Sci. USA. 1998. Vol. 95. P. 9813-9818.
180. Kim Y.-G., Cha J., Chandrasegaran S. Hybrid restriction enzymes: Zinc finger fusions to FokI cleavage domain // Proc. Nat. Acad. Sci. USA. 1996. Vol. 93. P. 1156-1160.
181. Kumar A., Grimes B., Logan M. et al. A hybrid sigma subunit directs RNA polymerase to a hybrid promoter in Escherichia coli // J. Mol. Biol. 1995. Vol. 246. P. 563-571.
182. Mencia М., Monsalve М., Rojo F., Salas M. Substitution of the C-terminal domain of the Escherichia coli RNA polymerase a subunit by that from Bacillus subtilis makes the enzyme responsive to a Bacillus subtilis transcriptional activator//Ibid. 1998. Vol. 275. P. 177-185.
183. Betton J.M., Jacob J.P., Hofnung М., Broome-Smith J.K. Creating a bifunctional protein by insertion of a (3-lactamase into maltodextrin-bind-ing protein // Nature Biotechnol. 1997. Vol. 15. P. 1276-1279.
184. Brennan С A., Christianson K., La Fleur MA., Mandecki W. A molecular sensor system based on genetically engineered alkaline phosphatase // Proc. Nat. Acad. Sci. USA. 1995. Vol. 92. P. 5783-5787.
185. Fushinobu S., Ohta Т., Matsuzawa H. Homotropic activation via the subunit interaction and allosteric symmetry revealed on analysis of hybrid enzymes of L-lactate dehydrogenase // J. Biol. Chem. 1998. Vol. 273. P. 2971-2976.
186. Hastings J.W. Chemistries and colors of bioluminescent reactions: A review I I Gene. 1996. Vol. 173, N 1: Special number. P. 5-11.
187. Lewis J.C., Daunert S. Photoproteins as luminescent labels in binding assays // Fresenius J. Anal. Chem. 2000. Vol. 366. P. 760-768.
188. Shimomura O. A short story of aequorin // Biol. Bull. 1995. Vol. 189, N 1. P. 1-5.
189. Johnson F.H., Shimomura О., Saiga Y. et al. // J. Cell. Comp. Physiol. 1962. Vol. 60. P. 85.
190. Deo S.K., Daunert S. Luminescent proteins from Aequorea victoria: Applications in drug discovery and in high throughput analysis I I Fresenius J. Anal. Chem. 2001. Vol. 369. P. 258-266.
191. Pauseh M.H. G-protein-coupled receptors in Saccharomyces cerevisiae: High-throughput screening assays for drug discovery // Trends Biotechnol.
1997. Vol. 15, N 12. P. 487^94.
192. Ungrin M.D., Singh L.M., Stocco R. et al. An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors // Anal. Biochem. 1999. Vol. 272, N 1. P. 34-42.
193. WahlforsJ., Loimas S., Pasanen Т., Hakkarainen T. Green fluorescent protein (GFP) fusion constructs in gene therapy research // Histochem. Cell. Biol. 2001. Vol. 115. P. 59-65.
194. Verkhusha V.V., Lukyanov К A. The molecular properties and applications of Anthozoa fluorescent proteins and chromoproteins // Nature Biotechnol. 2004. Vol. 22. P. 289-296.
195. Reiter Y., Pastan /. Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis // Trends Biotechnol. 1998. Vol. 16. P. 513-520.
196. Falnes P.0., Sandvig K. Penetration of protein toxins into cells I I Curr. Opin. Cell Biol. 2000. Vol. 12. P. 407^13.
197. Kreitman R.J. Immunotoxins in cancer therapy I I Curr. Opin. Immunol.
1999. Vol. 11. P. 570-578.
198. White С A., Weaver R.L., Grillo-Lopez A.I. Antibody-targeted immunotherapy for treatment of malignancy I I Annu. Rev. Med. 2001. Vol. 52. P. 125-145.
199. Weinberg A.D. 0X40: Targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines // Trends Immunol. 2002. Vol. 23. P. 102-108.
200. Brown J.R., Doolittle W.F. Archaea and the prokaryote-to-eukaryote transition//Microbiol. Mol. Biol. Rev. 1997. Vol. 61. P. 456-502.
201. Hough D.W., Danson M.J. Extremozymes // Curr. Opin. Chem. Biol. 1999. Vol. 3. P. 39-46.
